Type
1.
Butler J Department of Microbial Sciences, School of Biosciences and Medicine, University of Surrey, Haslemere, Surrey, UK, Ogden J School of Psychology, University of Surrey, Guildford, UK, Phillips R Kumasi Centre for Collaborative Research, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, Hay R King’s College London, Strand, London, UK, Simmonds RE Department of Microbial Sciences, School of Biosciences and Medicine, University of Surrey, Guildford, UK, Erolin C Center for Anatomy and Human Identification, University of Dundee, Medical Sciences Institute, Dundee, UK. Multisensory medical illustrations of Buruli ulcer for improved disease detection, help seeking behaviour and adherence to treatment. Journal of Visual Communication in Medicine [Internet]. 2024;:1-13. Available from: https://www.tandfonline.com/doi/pdf/10.1080/17453054.2024.2348170
Type
1.
Gyapong JO, Boatin BA, editors. Neglected Tropical Diseases - Sub-Saharan Africa. 2nd ed. Neglected Tropical Diseases. Springer International Publishing; 2024.
Type
1.
Tuwor RD, Mtuy TB, Amoako YA, Owusu L, Oppong MN, Agbanyo A, et al. Stigma experiences, effects and coping among individuals affected by Buruli ulcer and yaws in Ghana. PLoS neglected tropical diseases [Internet]. 2024;18(4):1-19. Available from: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0012093&type=printable
Type
1.
Mee PT, Buultjens AH, Oliver J, Brown K, Crowder JC, Porter JL, et al. Mosquitoes provide a transmission route between possums and humans for Buruli ulcer in southeastern Australia. Nature Microbiology [Internet]. 2024;9(2):377-89. Available from: https://www.nature.com/articles/s41564-023-01553-1.pdf
Type
1.
Shyam M, Kumar S, Singh V. Unlocking Opportunities for Mycobacterium leprae and Mycobacterium ulcerans. ACS infectious diseases. 2024;
Type
1.
Boccarossa A, Fleuret S. Mixed Research Methods for Buruli Ulcer Prevention in Southern Benin Using Geographic Health Surveys. In: Global Perspectives on Health Geography. Springer International Publishing; 2023. pp. 91-114.
Type
1.
Warryn L, Pluschke G. Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease. CHIMIA [Internet]. 2023;77(9):577-81. Available from: https://www.chimia.ch/chimia/article/view/2023_577/6291
Type
1.
McNamara BJ, Blasdell KR, Yerramilli A, Smith IL, Clayton SL, Dunn M, et al. Comprehensive Case-Control Study of Protective and Risk Factors for Buruli Ulcer, Southeastern Australia. Emerging infectious diseases [Internet]. 2023;29(10):2032-43. Available from: https://wwwnc.cdc.gov/eid/article/29/10/pdfs/23-0011.pdf
Type
1.
Vandelannoote K Department of Microbiology and Immunology, University of Melbourne, Buultjens AH Department of Microbiology and Immunology, University of Melbourne, Porter JL Department of Microbiology and Immunology, University of Melbourne, Velink A Department of Microbiology and Immunology, University of Melbourne, Wallace JR Department of Biology, Millersville University, Blasdell KR CSIRO Health and Biosecurity, et al. Statistical modelling based on structured surveys of Australian native possum excreta harbouring Mycobacterium ulcerans predicts Buruli ulcer occurrence in humans. eLife [Internet]. 2023;12. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10154024/pdf/elife-84983.pdf
Type
1.
Chandenier J, Chippaux J-P, Gazin P, Jannin J, Solano P. Contrôle, élimination, éradication : où en est-on dans les MTN ? Journée scientifique de la SFMTSI du 25 novembre 2021. Medecine tropicale et sante internationale [Internet]. 2021;1(4). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128498/pdf/mtsi-01-5326.pdf